BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22552717)

  • 1. Schizophyllan inhibits the development of mammary and hepatic carcinomas induced by 7,12 dimethylbenz(α)anthracene and decreases cell proliferation: comparison with tamoxifen.
    Mansour A; Daba A; Baddour N; El-Saadani M; Aleem E
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1579-96. PubMed ID: 22552717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mangiferin Inhibits Inflammation and Cell Proliferation, and Activates Proapoptotic Events via NF-κB Inhibition in DMBA-Induced Mammary Carcinogenesis in Rats.
    Wang X; Yuwen T; Yanqin T
    J Environ Pathol Toxicol Oncol; 2021; 40(2):1-9. PubMed ID: 33822512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites of droloxifene in the cytosol of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
    Kawamura I; Lacey E; Tanaka Y; Nishigaki F; Manda T; Shimomura K
    Jpn J Cancer Res; 1994 Jun; 85(6):639-44. PubMed ID: 8063618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime Genistein Intake Increases the Response of Mammary Tumors to Tamoxifen in Rats.
    Zhang X; Cook KL; Warri A; Cruz IM; Rosim M; Riskin J; Helferich W; Doerge D; Clarke R; Hilakivi-Clarke L
    Clin Cancer Res; 2017 Feb; 23(3):814-824. PubMed ID: 28148690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wakame seaweed suppresses the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats.
    Funahashi H; Imai T; Tanaka Y; Tsukamura K; Hayakawa Y; Kikumori T; Mase T; Itoh T; Nishikawa M; Hayashi H; Shibata A; Hibi Y; Takahashi M; Narita T
    Jpn J Cancer Res; 1999 Sep; 90(9):922-7. PubMed ID: 10551319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated TGFB signalling in macrophages decreases susceptibility to DMBA-induced mammary cancer in mice.
    Sun X; Bernhardt SM; Glynn DJ; Hodson LJ; Woolford L; Evdokiou A; Yan C; Du H; Robertson SA; Ingman WV
    Breast Cancer Res; 2021 Mar; 23(1):39. PubMed ID: 33761981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-breast cancer potential of SS5020, a novel benzopyran antiestrogen.
    Suzuki N; Liu X; Laxmi YR; Okamoto K; Kim HJ; Zhang G; Chen JJ; Okamoto Y; Shibutani S
    Int J Cancer; 2011 Feb; 128(4):974-82. PubMed ID: 20824696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.
    Andersen TT; Georgekutty J; Defreest LA; Amaratunga G; Narendran A; Lemanski N; Jacobson HI; Bennett JA
    Br J Cancer; 2007 Aug; 97(3):327-33. PubMed ID: 17637684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumour Property of
    Akhouri V; Kumar A; Kumari M
    Breast Cancer (Auckl); 2020; 14():1178223420951193. PubMed ID: 32913391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological sex differences in hepatic response to in utero dimethylbenz(a)anthracene exposure.
    Inyang I; White HE; Timme K; Keating AF
    Reprod Toxicol; 2024 Mar; 124():108553. PubMed ID: 38307155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophyllan from Schizophyllum commune BRM 060008: Potential application as an inhibitor of lipase.
    Mancinelli KCB; Dalonso N; Pezzin APT; Sassaki GL; de Oliveira Petkowicz CL; Lima DD; Moritz AHL; Alberton MD; Erzinger GS
    Int J Biol Macromol; 2024 Feb; 259(Pt 1):129108. PubMed ID: 38158055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the benefits of split gill mushroom: Chemical analysis and prebiotic properties of schizophyllan extract.
    Saetang N; Ramaraj R; Praphruet R; Unpaprom Y
    Int J Biol Macromol; 2023 Dec; 252():126544. PubMed ID: 37634777
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ubhenin AE; Adefolalu AA; Oriakhi K; Adamude FA; Dingwoke EJ; Ikebuiro JO; Chiwendu BC; Muhammad ML; Omage K
    Heliyon; 2024 Jan; 10(1):e23401. PubMed ID: 38187255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Activities of
    Putra WE; Rifa'i M
    Adv Pharm Bull; 2019 Oct; 9(4):619-623. PubMed ID: 31857966
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular interaction and MD-simulations: investigation of Sizofiran as a promising anti-cancer agent targeting eIF4E in colorectal cancer.
    Samykannu G; Mariyappan N; Natarajan J
    In Silico Pharmacol; 2024; 12(1):33. PubMed ID: 38655099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.
    Zhang L; Chai D; Chen C; Li C; Qiu Z; Kuang T; Parveena M; Dong K; Yu J; Deng W; Wang W
    Front Microbiol; 2022; 13():946995. PubMed ID: 35910636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review.
    Yen C; Zhao F; Yu Z; Zhu X; Li CG
    Front Pharmacol; 2022; 13():847113. PubMed ID: 35721162
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticancer Activities of Mushrooms: A Neglected Source for Drug Discovery.
    Panda SK; Sahoo G; Swain SS; Luyten W
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobiome and Cancer: What Is the Evidence?
    Vallianou N; Kounatidis D; Christodoulatos GS; Panagopoulos F; Karampela I; Dalamaga M
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exopolysaccharide-peptide complex from oyster mushroom (
    Abdel-Monem NM; El-Saadani MA; Daba AS; Saleh SR; Aleem E
    Biochem Biophys Rep; 2020 Dec; 24():100852. PubMed ID: 33241128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.